Under-Recruitment of Brain Regions May be Linked With Postchemotherapy Cognitive Impairment

Cancer-related cognitive impairments in patients receiving adjuvant chemotherapy may be associated with under-recruitment of brain regions.
Cancer-related cognitive impairments in patients receiving adjuvant chemotherapy may be associated with under-recruitment of brain regions.

Cancer-related cognitive impairments in patients receiving adjuvant chemotherapy may be associated with under-recruitment of brain regions involved in working and recognition memory, according to a small study published online ahead of print in Cancer.

Researchers led by Lei Wang, PhD, of the Northwestern University Feinberg School of Medicine in Chicago, Illinois, looked at 15 oncology patients who showed evidence of cognitive impairment according to neuropsychological testing as well as self-reporting after receiving adjuvant chemotherapy. They were matched by age and education with 14 cognitively normal control patients.

Patients were asked to perform a nonverbal -back working memory and visual recognition task during functional magnetic resonance imaging.

The researchers found that with working memory task, when 1-back and 2-back data were averaged with 0-back data, there was significantly reduced activation in the right dorsolateral prefrontal cortex for oncology patients compared with the control group.

In the recognition task, they also found that oncology patients displayed lower activity of the left-middle hippocampus compared to the control group.

“These results suggest that there is a reduction in neural functional postchemotherapy and corroborate patient-reported cognitive difficulties after cancer treatment, although a direct association was not observed,” the authors concluded.

REFERENCE

1. Wang L, Apple AC, Schroeder MP, et al. Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls. Cancer [published online ahead of print October 20, 2015]. doi:10.1002/cncr.29737.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs